Hey Mateo335,
Dr. David Stamler has confirmed in multiple presentations that peak sales of ATH434 will be approximately $1.1B USD. He also mentioned this to be a very conservative figure, especially if the drug gets prescribed off-label for other Parkinsonian diseases.
On another topic, as disappointing as the SP level is right now, we should all never lose sight of the bigger picture. The fundamentals for Alterity are there for all to see. We have overcome so many different challenges and hurdles over the years to get to this point. The finish line is almost in sight. A success outcome will be determined within the next 6 months. Dr Stamler has 120,000,000 reasons to make sure Alterity is a success.
Stockman
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-80
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $648.3K | 128.1M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4901441 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 22097257 | 20 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |